Sanofi India Limited — Board Meeting, 04-08-2026: Outcome of Board Meeting
04-08-2026 | 08:21 pm
04-08-2026 | 08:21 pm
Sanofi India's board approved its Q2 & H1 financial results. Profits before tax jumped 19% to ₹112.3 Cr, driven by 8% domestic sales growth and a 14% surge in its insulin portfolio. The company also announced a CFO change, effective September 30.
No comments yet. Be the first to comment!
